CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273181608
- Phone
- 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 8-K Event Other events
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K/A Event Exhibits
Page 31 of 41 · 818 filings